This is extremely promising for csl112. Even if it misses primary endpoint it can still be given fda approval?
https://endpts.com/failed-pivotal-study-you-can-still-have-breakthrough-therapy-status-fda-signals-to-resverlogix/
This is extremely promising for csl112. Even if it misses...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$309.72 |
Change
0.430(0.14%) |
Mkt cap ! $149.6B | |||
| Open | High | Low | Value | Volume |
| $310.10 | $311.54 | $308.61 | $295.6M | 953.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 14819 | $309.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $310.00 | 36 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |